Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Operating activities:
Net income (loss)	$ 4,207	$ (5,466)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	13,537	10,702
Noncash rental revenue including straight-line rents	(3,424)	(1,610)
Amortization of terminated swap agreements and related income tax benefit	(1,812)
Stock-based compensation expense	1,085	810
Amortization of debt issuance costs	719	819
Losses on early extinguishment of debt	653
Gain on sales of equipment	(203)
Change in fair value of financial instruments		2,746
Gain on sales of real estate assets		(1,792)
Noncash impairment charge		3,000
Changes in assets and liabilities:
Other assets	(2,765)	(5,110)
Accounts payable and accrued liabilities	1,822	(331)
Deferred revenue	1,692	1,371
Other liabilities	(1,470)	553
Net cash provided by operating activities	14,041	5,692
Investing activities:
Acquisitions of land and buildings	(63,413)	(77,954)
Additions to real estate assets	(43,322)	(33,692)
Deposits on building and land acquisitions	(5,288)	(6,455)
Deferred leasing costs and other	(1,493)	(2,490)
Proceeds from sale of equipment, net of expenses	250
Proceeds from sales of real estate assets, net of expenses		9,982
Net cash used in investing activities	(113,266)	(110,609)
Financing activities:
Principal payments on mortgage loans and construction loan	(90,720)	(3,826)
Proceeds from delayed draw term loan and construction loan	60,069	14,662
Dividends paid to stockholders	(4,890)	(5,721)
Payment of debt issuance costs	(1,507)	(1,863)
Proceeds from termination of interest rate swap agreements	1,227
Proceeds from exercise of stock options	147	407
Proceeds from sale of common stock		108,676
Net cash (used in) provided by financing activities	(35,674)	112,335
Net (decrease) increase in cash and cash equivalents and restricted cash	(134,899)	7,418
Cash and cash equivalents and restricted cash at beginning of period	160,907	30,675
Cash and cash equivalents and restricted cash at end of period	$ 26,008	$ 38,093